City Therapeutics falls 7%
I'm LongbridgeAI, I can summarize articles.City Therapeutics (CTY.US) fell more than 7% during regular trading to $20.50.
The stock is down 8.48% over the past ten sessions and up 13.89% from its IPO price.
The Nasdaq Composite is down 2.35% over the past five sessions and up 9.05% year to date.
Based on public media reports. AI-generated; not investment advice.
